VahidB, Machare-DelgadoE, MarikP. Acute unilateral pneumonitis in a patient with polymyositis: a unique presentation of polymyositis-associated pneumonitis. Respir Care, 2007; 52(12):1774–1778.
KolerRA, MontemaranoA. Dermatomyositis. Am Fam Physician, 2001; 64(9):1565–1572.
7.
NishikaiM, OhyaK, KosakaM, AkiyaK, TojoT. Anti-JO-1 antibodies in polymyositis or dermatomyositis evaluation by ELISA using recombinant fusion protein JO-1 as antigen. Br J Rheumatol, 1998; 37(4):357–361.
8.
BonnefoyO, FerrettiG, CalaqueO, CoulombM, BegueretH, Beylot-BarryM, LaurentF. Serial chest CT findings in interstitial lung disease associated with polymyositis-dermatomyositis. Eur J Radiol, 2004; 49(3):235–244.
9.
ChoyEH, IsenbergDA. Treatment of dermatomyositis and polymyositis. Rheumatology (Oxford), 2002; 41(1):7–13.
10.
DouglasWW, TazelaarHD, HartmanTE, HartmanRP, DeckerPA, SchroederDR, RyuJH. Polymyositis-dermatomyositis interstitial lung disease. Am J Respir Crit Care Med, 2001; 164(7):1182–1185.
11.
KastelerJS, CallenJP. Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis. J Am Acad Dermatol, 1997; 36(1):67–71.
12.
Zieglschmid-AdamsME, PandyaAG, CohenSB, SontheimerRD. Treatment of dermatomyositis with methotrexate. J Am Acad Dermatol, 1995; 32(5 Pt 1):754–757.
